Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Iterum Therapeutics plc
ITRM | US
0.18
USD0.01
8.04%
ITRM | US
Loading StockChartView...
About Iterum Therapeutics plc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
0.18
Open
0.17
High
0.18
Low
0.16
Iterum Therapeutics plc a clinical-stage pharmaceutical company engages in developing and commercializing anti-infectives in Ireland Bermuda and the United States. It is developing sulopenem a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections complicated urinary tract infections and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin Ireland.
View LessITRM | US
Risk
206.9
Sharpe
-0.95
Luna's Score
34/100
Recommendation
Sell
Luna says (ITRM | US)
What's Working
Low Debt to Equity (< 0.25)
What's not Working
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
276.8%1 month
206.9%3 months
136.3%6 months
114.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
6.03
Debt to equity
-1.98
Debt to assets
1.53
Ent. to EBITDA
0.55
Ent. to rev.
105.22
PEG
-
Other Fundamentals
EBITDA
-37.36M
MarketCap
4.06M
MarketCap(USD)
4.06M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-100.00
Ret. on equity
-555.68
Short ratio
0.63
Short perc.
0.98
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.16
Range1M
0.18
Range3M
0.35
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.40
Price X volume
127.64K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.55 | 0.53 | Par |
| Ent. to Revenue | 105.22 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 6.03 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 136.25 | 72.80 | Riskier |
| Debt to Equity | -1.98 | -1.23 | Cheaper |
| Debt to Assets | 1.53 | 0.25 | Expensive |
| Market Cap | 4.06M | 3.66B | Emerging |
